1-7 of 7
Joerg Faber
Close
Sort by
Journal Articles

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Gabriele Escherich, MD, Udo Zur Stadt, PhD, Dagmar Dilloo, MD, Joerg Faber, MD PhD, Tobias Feuchtinger, MD, Thomas Imscheiler, MD, Norbert Jorch, MD, Arnulf Pekrun, Irene Schmid, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-136149
Published: 2020
Journal Articles

Hemophagocytic Lymphohistiocytosis in Early Infancy- Pitfall of Differentiation between Hereditary and Infectious Reasons

Alexandra Russo, MD, Francesca Alt, MD, Marie Astrid Neu, MD, Stefan Eder, MD, Arthur Wingerter, MD, Khalifa El Malki, MD, Bernhard Lammle, MD, Joerg Faber, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4961.
https://doi.org/10.1182/blood-2018-99-117519
Published: 2018
Journal Articles

A New Algorithm and Panel Construction for Pediatric Leukemia Immunophenotyping Using 10-Color Flow Cytometry

Bettina Keller, Ph.D., Markus P Radsak, M.D., Joerg Faber, M.D., Alexandra Russo, M.D.
Journal: Blood
Blood (2012) 120 (21): 4799.
https://doi.org/10.1182/blood.V120.21.4799.4799
Published: 2012
Journal Articles

Demonstration of a Role for Dot1l In MLL -Rearranged Leukemia Using a Conditional Loss of Function Model

Kathrin M Bernt, MD, Nan Zhu, PhD, Joerg Faber, M.D., Natalie Punt, Roy M Pollock, PhD, Victoria M Richon, PhD, Andrew L. Kung, MD, PhD, Scott Armstrong, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 62.
https://doi.org/10.1182/blood.V116.21.62.62
Published: 2010
Journal Articles

HOXA9 is required for survival in human MLL -rearranged acute leukemias

Joerg Faber, Andrei V. Krivtsov, Matthew C. Stubbs, Renee Wright, Tina N. Davis, Marry van den Heuvel-Eibrink, Christian M. Zwaan, Andrew L. Kung, Scott A. Armstrong
Journal: Blood
Blood (2009) 113 (11): 2375–2385.
https://doi.org/10.1182/blood-2007-09-113597
Published: 2009
Includes: Supplemental data
Journal Articles

HOXA9 Represses Bim Expression in MLL Rearranged Leukemia: Implications for Drug Therapy.

Matthew C. Stubbs, PhD, Joerg Faber, M.D., Ph.D., Andrew L. Kung, M.D., Ph.D., Scott Cameron, M.D., Ph.D., Scott A. Armstrong, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 57.
https://doi.org/10.1182/blood.V110.11.57.57
Published: 2007
Journal Articles

Global Increase in H3K79 Dimethylation in Murine and Human MLL-AF4 Lymphoblastic Leukemias.

Andrei V. Krivtsov, PhD, Zhaohui Feng, Madeleine Lemieux, Joerg Faber, MD, PhD, Xiaobo Xia, PhD, Andrew L. Kung, MD, PhD, Scott A. Armstrong, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 344.
https://doi.org/10.1182/blood.V110.11.344.344
Published: 2007